Evolution of the NanoBiosensor
VOC Health’s NanoBiosensor uses carbon nanotubes, just a molecule in width, to detect and analyze volatile organic compounds (VOCs). The initial success of VOC Health and its partners was with the detection of stage I ovarian cancer, from a standard blood sample, with 95% sensitivity and 99% specificity in 58 lab-bench tests. These tests were […]
The Cube™ – early disease detection
Designed for Multi-Cancer Early Detection (MCED) tests for over 40 cancers, the latest prototype of the Cube™ will also aim to detect infectious diseases using a single, 5ml sample of blood or urine. The Cube is a desktop lab device designed to precisely extract volatile organic compounds (VOCs) from any liquid sample (e.g. blood or urine) as […]
The Wave® – contactless COVID-19 detection
Designed for high-volume, rapid disease detection, the Wave® device uses two on-board NanoBiosensors to detect COVID-19. Just hold your hand above the device for a few seconds and the Wave® will detect and analyze volatile organic compounds (VOCs) in the vapor emitted from the palm of your hand. A positive or negative result is provided after a few […]
Clinical Trials in FL
VOC Health has completed the first field test of the Wave device, designed for contactless COVID-19 detection in seconds. Using two of our proprietary NanoBiosensors, the Wave analyzes the volatile organic compounds (VOCs) emitted from the palm of your hand. From there, our algorithms can determine the presence of COVID-19 and we believe, many other […]